Cite
HARVARD Citation
Phan, A. et al. (n.d.). Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study. Lancet oncology. 16 (6), pp. 695-703. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Phan, A. et al. (n.d.). Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study. Lancet oncology. 16 (6), pp. 695-703. [Online].